Community Bank of Raymore Takes Position in Stryker Co. (NYSE:SYK) – Polson News

Community Bank of Raymore bought a new stake in shares of Stryker Co. (NYSE:SYK) during the 3rd quarter, according to its most recent filing with the SEC. The fund bought 1,210 shares of the medical technology companys stock, valued at approximately $262,000.

Several other institutional investors have also modified their holdings of the company. Benjamin F. Edwards & Company Inc. boosted its position in shares of Stryker by 10.2% during the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 15,332 shares of the medical technology companys stock valued at $3,316,000 after acquiring an additional 1,415 shares in the last quarter. Benjamin Edwards Inc. boosted its position in shares of Stryker by 10.4% during the 3rd quarter. Benjamin Edwards Inc. now owns 617 shares of the medical technology companys stock valued at $133,000 after acquiring an additional 58 shares in the last quarter. Carillon Tower Advisers Inc. acquired a new stake in shares of Stryker during the 3rd quarter valued at about $2,639,000. Brasada Capital Management LP boosted its position in shares of Stryker by 3.0% during the 3rd quarter. Brasada Capital Management LP now owns 3,327 shares of the medical technology companys stock valued at $720,000 after acquiring an additional 97 shares in the last quarter. Finally, CNB Bank boosted its position in shares of Stryker by 18.0% during the 3rd quarter. CNB Bank now owns 813 shares of the medical technology companys stock valued at $176,000 after acquiring an additional 124 shares in the last quarter. Institutional investors and hedge funds own 73.13% of the companys stock.

Shares of NYSE SYK opened at $199.78 on Friday. Stryker Co. has a 1-year low of $144.75 and a 1-year high of $223.45. The company has a market cap of $74.21 billion, a PE ratio of 27.33, a P/E/G ratio of 2.43 and a beta of 0.80. The company has a current ratio of 2.18, a quick ratio of 1.35 and a debt-to-equity ratio of 0.64. The company has a 50-day moving average of $213.13 and a two-hundred day moving average of $205.63.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, October 29th. The medical technology company reported $1.91 earnings per share for the quarter, topping the Zacks consensus estimate of $1.90 by $0.01. Stryker had a net margin of 23.55% and a return on equity of 25.33%. The company had revenue of $3.59 billion during the quarter, compared to the consensus estimate of $3.58 billion. During the same period in the previous year, the firm posted $1.69 earnings per share. The companys revenue was up 10.6% on a year-over-year basis. As a group, equities research analysts forecast that Stryker Co. will post 8.23 earnings per share for the current year.

Several equities analysts recently issued reports on the stock. BTIG Research set a $228.00 price target on shares of Stryker and gave the company a buy rating in a report on Thursday, September 5th. Barclays downgraded shares of Stryker from an overweight rating to an equal weight rating and cut their price target for the company from $226.00 to $207.00 in a report on Tuesday, November 5th. Raymond James set a $240.00 price target on shares of Stryker and gave the company a buy rating in a report on Friday, July 26th. Royal Bank of Canada set a $220.00 price target on shares of Stryker and gave the company a buy rating in a report on Friday, July 26th. Finally, ValuEngine downgraded shares of Stryker from a buy rating to a hold rating in a report on Wednesday, October 2nd. Six equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the companys stock. Stryker has a consensus rating of Buy and a consensus price target of $220.17.

In other Stryker news, VP M Kathryn Fink sold 28,690 shares of the businesss stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $220.97, for a total value of $6,339,629.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Timothy J. Scannell sold 4,666 shares of the businesss stock in a transaction that occurred on Wednesday, October 16th. The stock was sold at an average price of $214.50, for a total transaction of $1,000,857.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 67,524 shares of company stock valued at $14,731,927. Insiders own 7.20% of the companys stock.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Story: Initial Public Offering (IPO)

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

See original here:

Community Bank of Raymore Takes Position in Stryker Co. (NYSE:SYK) - Polson News